Jun 17, 2009
By:
George Koroneos, Online Content & News Editor
In an effort to learn as more about epilepsy sufferers, UCB will implement a social network that allows patients to communicate about their disease state and treatments. Think of it as one giant, online clinical trial.
|
Jun 11, 2009
By:
George Koroneos, Online Content & News Editor
The Word Health Organization just bumped the H1N1 influenza to pandemic alert phase 6 (the highest alert level), making it the first worldwide pandemic in 41 years.
|
Jun 10, 2009
By:
George Koroneos, Online Content & News Editor
What do you do when you are introducing a new drug in an already crowded category? Wyeth queried depression sufferers to find out what they want to see in a drug ad before launching its new DTC campaign for Pristiq.
|
Jun 10, 2009
By:
George Koroneos, Online Content & News Editor
GlaxoSmithKline is expanding its influenza vaccine efforts through a joint R&D alliance with Shenzhen Neptunus. The goal: to tap the world’s biggest market and attempt to deliver flu shots to more than a billion people.
|
Jun 3, 2009
By:
George Koroneos, Online Content & News Editor
The feds green lit a task force charged with easing the flow of communication between FDA, pharma companies, and the general public. While the team is being billed as a task force for transparency, it?s still unclear what is being revealed.
|
Jun 3, 2009
By:
George Koroneos, Online Content & News Editor
GlaxoSmithKline has entered into a collaboration deal with Concert to create drugs using deuterium—“heavy hydrogen”—that can be gathered from seawater and used to alter the way molecules perform in the body.
|
May 27, 2009
By:
George Koroneos, Online Content & News Editor
Cancer patients worry not only about their disease, but also the side effects of the drugs they take to treat it. Now the Centers for Disease Control and Prevention and biologics firm Amgen are partnering on a multi-prong program to get patients to pay attention to another, related, danger: chemo-related infections.
|
May 27, 2009
By:
George Koroneos, Online Content & News Editor
You know those loud soundtracks and distracting visuals during the safety information in your TV ads? Critics have been complaining about them, and new draft guidance from FDA is calling them a "no-no."
|
|
PharmExec Blog
Follow Us
RSS
Bookstore
